CSPG4 and acute myeloid leukemia: Chondroitin sulfate proteoglycan 4 (CSPG4) was also lower in the secretomes of AML-MSCs compared to D-MSCs both at the onset (Log2FC = −3.2, p = 0.001) and in remission (Log2FC = −2.85, p = 0.006).